Dr. Monte Alton Thames Jr., MD

Dr. Thames practices at Baton Rouge General Medical Center - Bluebonnet in Baton Rouge, Louisiana.

Dr. Thames' NPI, 1619160819, was assigned on August 21, 2007. Dr. Thames holds Louisiana license MD.202214.

Dr. Thames' primary practice is Baton Rouge General Medical Center - Bluebonnet, at 8585 Picardy Ave, Baton Rouge, LA 70809 in East Baton Rouge Parish. The practice phone is (225) 387-7000.

Dr. Thames' primary practice is Baton Rouge General Medical Center - Bluebonnet in Baton Rouge, Louisiana. Dr. Thames is also affiliated with Baton Rouge General - Bluebonnet. The medical group on file is C&M Medical Services. Dmand AI also links Dr. Thames to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thames practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Thames' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Thames is licensed in Louisiana.

CMS data shows 628 Medicare services from Dr. Thames across 4 procedure codes in 2024, for 382 Medicare patients. Medicare paid $55,214 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 382 Medicare patients who saw Dr. Thames in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thames' median patient age at 48, with 61% women.

In 2024, Dr. Thames wrote 98 Medicare Part D claims for 73 patients. 95% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $74 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Thames for performance year 2024, reported as part of a group. Dr. Thames accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Thames from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $19.